MONMOUTH JUNCTION, NJ–(Marketwired – January 07, 2016) – DiamiR Biosciences, a developer of innovative minimally invasive diagnostic tests for early detection and monitoring of neurodegenerative diseases based on analysis of brain-enriched microRNA pairs in plasma, announced today the formation of its Advisory Board with three members: Dr. Mikhail Denissenko, Dr. Kevin Krenitsky, and Dr. Laura Philips.